APA (7th ed.) Citation

Askanase, A. D., Furie, R., Dall'Era, M., Bomback, A. S., Schwarting, A., Zhao, M., . . . Urowitz, M. B. (2025). Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents. Rheumatology & Therapy, 12(3), 421. https://doi.org/10.1007/s40744-025-00752-y

Chicago Style (17th ed.) Citation

Askanase, Anca D., et al. "Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents." Rheumatology & Therapy 12, no. 3 (2025): 421. https://doi.org/10.1007/s40744-025-00752-y.

MLA (9th ed.) Citation

Askanase, Anca D., et al. "Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents." Rheumatology & Therapy, vol. 12, no. 3, 2025, p. 421, https://doi.org/10.1007/s40744-025-00752-y.